Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Clemmons, et al
545 In the development of drugs for UC, in addition to continuing to optimize existing drug targets and therapeutic strategies, we should also focus on the development of drugs with novel mechanisms of action
This article is intended for educational purposes only and does not constitute medical advice
Manufactured in the U.S.A
Remarkably, however, it is still not understood why the glucagon response is deficient or even absent in individuals with type 1 diabetes (and long-standing type 2 diabetes [58]), where this deficient response appears to be independent of the presence or absence of autonomic neuropathy [59]
